RFID Firm Benefits From Counterfeits

BMI View: Improvements in supply chain technologies in Argentina will contribute to reducing the current high levels of counterfeit medicines. BMI believes the promotion of generic medicines will benefit the Argentinean pharmaceutical industry by providing a more cost-effective treatment option for patients and discouraging demand for lower-cost counterfeits.

To read the full article, please choose one of the following options: